back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2021-05-06 17:04 Tx date 2020-10-26 |
$ICO
iCo Therapeutics Inc. |
Koppy, Susan Lynne
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$10,500
+210,000 vol $0.05 each |
610,000 | |
| Filed 2021-05-06 13:16 Tx date 2021-04-30 |
$ICO
iCo Therapeutics Inc. |
Koppy, Susan Lynne
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$10,500
+210,000 vol $0.05 each |
610,000 | |
| Filed 2021-05-06 13:14 Tx date 2020-01-10 |
$ICO
iCo Therapeutics Inc. |
Koppy, Susan Lynne
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$24,000
+300,000 vol $0.08 each |
400,000 | |
| Filed 2021-05-06 13:13 Tx date 2021-04-30 |
$ICO
iCo Therapeutics Inc. |
Koppy, Susan Lynne
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$10,500
+210,000 vol $0.05 each |
||
| Filed 2021-05-06 13:11 Tx date 2020-01-10 |
$ICO
iCo Therapeutics Inc. |
Koppy, Susan Lynne
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$24,000
+300,000 vol $0.08 each |
||
| Filed 2021-05-06 13:08 Tx date 2016-02-17 |
$ICO
iCo Therapeutics Inc. |
Koppy, Susan Lynne
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$5,000
+100,000 vol $0.05 each |
100,000 | |
| Filed 2021-05-06 12:59 Tx date 2020-10-26 |
$ICO
iCo Therapeutics Inc. |
Koppy, Susan Lynne
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$10,500
+210,000 vol $0.05 each |
610,000 | |
| Filed 2021-05-06 12:59 Tx date 2020-10-26 |
$ICO
iCo Therapeutics Inc. |
Koppy, Susan Lynne
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$10,500
+210,000 vol $0.05 each |
||
| Filed 2020-01-22 12:12 Tx date 2020-01-10 |
$ICO
iCo Therapeutics Inc. |
Koppy, Susan Lynne
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,000
+300,000 vol $0.08 each |
||
| Filed 2016-02-23 11:54 Tx date 2016-02-17 |
$ICO
iCo Therapeutics Inc. |
Koppy, Susan Lynne
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$5,000
+100,000 vol $0.05 each |
||
| Filed 2020-09-24 11:33 Tx date 2020-09-22 |
$ICO
iCo Therapeutics Inc. |
Jarosz, William Wasyl
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,750
+50,000 vol $0.035 each |
1,533,556 | |
| Filed 2020-09-24 11:32 Tx date 2020-09-22 |
$ICO
iCo Therapeutics Inc. |
Jarosz, William Wasyl
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,201
+235,000 vol $0.0349 each |
1,483,556 | |
| Filed 2020-09-24 11:30 Tx date 2020-09-22 |
$ICO
iCo Therapeutics Inc. |
Jarosz, William Wasyl
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,492
+272,000 vol $0.0349 each |
1,248,556 | |
| Filed 2020-09-14 14:41 Tx date 2020-09-11 |
$ICO
iCo Therapeutics Inc. |
Jarosz, William Wasyl
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$95,744
+273,556 vol $0.35 each |
976,556 | |
| Filed 2020-01-22 12:12 Tx date 2020-01-10 |
$ICO
iCo Therapeutics Inc. |
Koppy, Susan Lynne
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,000
+300,000 vol $0.08 each |
400,000 | |
| Filed 2020-01-17 13:13 Tx date 2020-01-10 |
$ICO
iCo Therapeutics Inc. |
Jarosz, William Wasyl
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$32,000
+400,000 vol $0.08 each |
900,000 | |
| Filed 2020-01-14 16:55 Tx date 2020-01-10 |
$ICO
iCo Therapeutics Inc. |
Liggett, Michael
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
450,000 | ||
| Filed 2020-01-14 12:42 Tx date 2020-01-10 |
$ICO
iCo Therapeutics Inc. |
Rae, Andrew Rae
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
1,390,000 | |
| Filed 2018-05-23 Tx date 2018-05-23 |
$ICO
iCo Therapeutics Inc. |
Rae, Andrew Rae
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,750
+250,000 vol $0.035 each |
4,573,010 | |
| Filed 2018-05-23 Tx date 2018-05-22 |
$ICO
iCo Therapeutics Inc. |
Rae, Andrew Rae
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,750
+450,000 vol $0.035 each |
4,323,010 | |
| Filed 2018-05-23 Tx date 2018-05-18 |
$ICO
iCo Therapeutics Inc. |
Rae, Andrew Rae
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,500
+500,000 vol $0.035 each |
3,873,010 | |
| Filed 2016-07-08 Tx date 2016-07-06 |
$ICO
iCo Therapeutics Inc. |
Rae, Andrew Rae
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,000
+400,000 vol $0.035 each |
3,373,010 | |
| Filed 2016-02-23 Tx date 2016-02-17 |
$ICO
iCo Therapeutics Inc. |
Koppy, Susan Lynne
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$5,000
+100,000 vol $0.05 each |
100,000 | |
| Filed 2016-02-23 Tx date 2015-12-24 |
$ICO
iCo Therapeutics Inc. |
Koppy, Susan Lynne
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-18 Tx date 2016-02-17 |
$ICO
iCo Therapeutics Inc. |
Meekison, William John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$5,000
+100,000 vol $0.05 each |
475,000 | |
| Filed 2016-02-10 Tx date 2016-02-10 |
$ICO
iCo Therapeutics Inc. |
Rae, Andrew Rae
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,920
+148,000 vol $0.04 each |
2,973,010 | |
| Filed 2016-02-09 Tx date 2016-02-09 |
$ICO
iCo Therapeutics Inc. |
Rae, Andrew Rae
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,575
+45,000 vol $0.035 each |
2,825,010 | |
| Filed 2016-02-09 Tx date 2016-02-08 |
$ICO
iCo Therapeutics Inc. |
Rae, Andrew Rae
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,995
+57,000 vol $0.035 each |
2,780,010 | |
| Filed 2016-01-25 Tx date 2016-01-25 |
$ICO
iCo Therapeutics Inc. |
Rae, Andrew Rae
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,090
+203,000 vol $0.03 each |
2,723,010 | |
| Filed 2016-01-25 Tx date 2016-01-22 |
$ICO
iCo Therapeutics Inc. |
Rae, Andrew Rae
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,410
+47,000 vol $0.03 each |
2,520,010 | |
| Filed 2016-01-21 Tx date 2016-01-21 |
$ICO
iCo Therapeutics Inc. |
Rae, Andrew Rae
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,730
+491,000 vol $0.03 each |
2,473,010 | |
| Filed 2016-01-21 Tx date 2016-01-20 |
$ICO
iCo Therapeutics Inc. |
Rae, Andrew Rae
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$225.00
+9,000 vol $0.025 each |
1,982,010 |